AstraZeneca Makes Big U-Turn, Admits Covishield Can Cause Rare Side Effect
Covishield, developed by AstraZeneca, was produced by the Serum Institute of India and widely administered in the country. British pharma giant AstraZeneca has admitted that its Covid vaccine can cause a rare side effect, The Telegraph (UK) has reported. Covishield can cause, in rare cases, a condition that leads to blot clots and low platelet count, the…
Share